Is It Time to Sell MercadoLibre?
MercadoLibre (NASDAQ:MELI) has earned a reputation for being not dissimilar…
Buy
59
COCO Quote, Financials, Valuation and Earnings
Last price:
$34.64
Seasonality move
:
6.74%
Day range:
$34.48 - $35.18
52-week range:
$23.56 - $40.32
Dividend yield:
0%
P/E ratio:
34.65x
P/S ratio:
3.90x
P/B ratio:
7.15x
Volume:
459.3K
Avg. volume:
798.7K
1-year change:
23.12%
Market cap:
$2B
Revenue:
$516M
EPS (TTM):
$1.01
The Vita Coco Number of Institutional Trades
The Vita Coco Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$1.6B
(Last 6 Months)
Current Institutional Ownership Percentage
89.81%
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$4.4B
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
The Vita Coco Institutional Ownership
-
What Percentage Of COCO Is Owned by Institutions?
89.81% of COCO is owned by institutions.
-
How Many Institutions Own COCO Shares?
The Vita Coco stock is owned by 450 institutional shareholders at this time.
-
Have Institutions Been Buying COCO Stock?
Yes, institutions have bought 26.5M shares of COCO in the last quarter.
-
Have Institutions Been Selling COCO Stock?
Yes, institutions have sold 59.7M shares of COCO over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Stock High Risk or High Reward?
EV-making supergiant Tesla, Inc. (NASDAQ:TSLA) is going through a difficult…
Why Did Chase Coleman Buy TSM?
Billionaire Chase Coleman of Tiger Global Management has built a…
Stock Ideas
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 48x
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
55
CTRN alert for Jun 5
Citi Trends [CTRN] is up 2.77% over the past day.
Sell
44
RGC alert for Jun 4
Regencell Bioscience Holdings [RGC] is up 3.45% over the past day.
Buy
63
MLTX alert for Jun 4
MoonLake Immunotherapeutics [MLTX] is up 5.33% over the past day.
